Aurobindo Pharma gets Canada nod for terbinafine
MUMBAI, Dec 24 (Reuters) - Drug maker Aurobindo Pharma Ltd (ARBN.BO: Quote, Profile, Research) said on Wednesday it received the Canadian regulatory approval to sell terbinafine hydrochloride tablets in multiple strengths.
The drug is the generic equivalent of Novartis' (NOVN.VX: Quote, Profile, Research) Lamisil indicated for the treatment of fungal infections in the skin and nails, the company said in a statement. (Reporting by Bharghavi Nagaraju; Editing by Prem Udayabhanu)
© Thomson Reuters 2009 All rights reserved
India Investment Summit 2009
Top executives and bankers discuss their own plans and the broader opportunities and challenges for India during the Reuters India Investment Summit in Mumbai and Bangalore. Full Coverage | Blog
PLAYBOY SALE
An icon bows to changing times
With his Playboy Enterprises in talks to be sold for about $300 million, the 83 year-old Hugh Hefner will be giving up control over the iconic adult entertainment empire he founded that was instrumental in shaping society's opinions on nudity, sex and free speech. Full Article
India
US
UK
